v3 Template
C

CraniUS™

Healthcare / Biotechnology ~220 employees
Founded
--
Employees (Est.)
~220
11 leaders known
Total Funding
$1.0M
Funding Rounds
1
Last Funding
2024-06-26

About CraniUS™

CraniUS Therapeutics is a company focused on revolutionizing the treatment of brain diseases through innovative drug delivery systems. Their mission is to define the future of diagnostics and treatments for patients with brain conditions such as aggressive brain tumors, Alzheimer's, and Parkinson's disease.

Products & Services

NeuroPASS™:The world's first and only skull-implanted drug delivery system designed to bypass the blood-brain barrier, delivering precise microdoses of medication directly to the brain for targeted treatment of brain tumors, Alzheimer's, and Parkinson's disease. Features include reduced systemic side effects, an invisible design, and MRI compatibility.

Specialties

Drug Delivery Systems Brain Tumor Treatment Neurological Disease Treatment Medical Device Innovation

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Grant
T: -
FT: Grant
A: 1000000
MR: -
FA: $1 million
FAN: 1000000
D: 2024-06-26
FD: 2024-06-26
1 investors
Grant Latest
2024-06-26
$1.0M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

M

Michael Maglin

Chief Executive Officer

LinkedIn (Pro only)
N

Natalie Wisniewski

Chief Product Officer

LinkedIn (Pro only)
E

Elizabeth Dale

Senior Advisor, Business Development

LinkedIn (Pro only)
A

AJ Mattia

Senior Advisor, Business Development

C

Chad Gordon

Founder and Executive Chair, Chief Medical Officer

S

Stephen Klasko

Executive in Residence, Catalyst Board Chair, DocGo

View 8 more team members with Pro

Unlock Full Team Directory

Recent News

CraniUS™ Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Healthcare / Biotechnology
Company Size
~220 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro